FDA Clinical Product Approval Seminar | February 21, 2017 Taipei, Taiwan

​

Amarex Clinical Research will host a seminar on optimizing clinical development for US FDA market approval. Key note speakers include the following Amarex team members: Dr. Kazem Kazempour, President & CEO, and Dr. Olga Pavlova, Regulatory Manager for the Department of Regulatory Affairs. Topics of discussion will include new FDA botanical drug guidance, 505(b)(2) vs ANDA and Biobetter vs Biosimilar, and accelerated product development.